I’m {role} in {country} and I agree to comply with the
terms of the website.
Why are you asking this?
By telling us your location and the type of visitor you are, we can show you the most relevant and interesting content and provide the best possible experience throughout the website. You can read our Privacy notice here.
Kamalanomics or Trump trade?
The contest for the next US presidency is gathering momentum. To what extent might the candidates’ economic policies be decisive for investors?
The elusive return on AI investment – it exists
Companies driving ahead in the AI innovation race are already seeing benefits and it’s not just the technology giants
The main parties’ manifestos – what does it mean?
Lang Cat have analysed the key policy proposals in the manifestos that will impact advisers and their clients after Thursday’s General Election.
State of the Advice Nation – what is keeping advice firm owners awake at night?
Lang Cat have surveyed advice firms to ask them what is keeping them awake at night.
The Granolas – Europe’s answer to the Magnificent Seven?
Are pharmaceutical stocks Europe’s answer to the tech ‘Magnificent Seven’ in the US? We take a look at a group of stocks dubbed the ‘Granolas’
In this episode of Global Infusions, Tom welcomes back Hong to explore the business of defence. From sanctions to drones, the consequences of war are legion.
Global Infusions Podcast
The Business of Nuclear
Listen on:
In this episode, Tom is joined by James to explore the business of nuclear energy. From power plants to uranium mines, the whole industry has entered the limelight and for good reason.
Global Infusions Podcast
The Business of Weight Loss
Listen on:
In this episode, Tom and Hong explore the business of losing weight. From gym subscriptions to new wonder drugs, the industry is changing like never before.